Andrew H. Schmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew H. Schmidt has a total of 306 co-authors. Here are the top co-authors by number of shared publications:
- Paul Tornetta
Department of Orthopaedic Surgery, Boston Medical Center, Boston, MA
10 shared publications David C. Templeman
Orthopaedic Surgery, Hennepin County Medical Center, Minneapolis, Minnesota
6 shared publicationsWilliam D. Lew
Midwest Orthopaedic Research Foundation
6 shared publications- William T. Obremskey
Vanderbilt University Medical Center, Nashville, TN
5 shared publications Craig A. Bourgeault
Orthopaedic Biomechanics Laboratory, Midwest Orthopaedic Research Foundation, 914 South 8th Street, Mail Code 860C, Minneapolis, MN 55404. address for W.D. Lew
4 shared publicationsXinqian Chen
Midwest Orthopaedic Research Foundation
4 shared publications
Latest Publications
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (2)
Rethinking the Paradigm of Using Ps for Diagnosing Compartment Syndrome
Background: To evaluate the predictive power of 7 clinical signs and symptoms associated with acute compartment syndrome (ACS) of the leg, namely pain, paresthesia, paralysis, pallor, poikilothermia, pulselessness, and pressure on palpation (7P's). Methods: Retrospective data of 357 patients were obtained from the databases of 5-level one trauma centers in Canada, the United States, and France. Inclusion criteria were patients with tibia injuries that received fasciotomies in adults with documented serial clinical assessments. All possible combinations of signs/symptoms used were generated. The combinations were tested for predictive power using 2 machine learning algorithms. Results: Pressure on palpation was the strongest clinical predictor of ACS while pain was the weakest. Using any single P to assess for ACS yields a poor prediction. Increasing the number of Ps improves the performance up to 4Ps, regardless of the composition of the combination. None of the combinations had a perfect predictive power which means that the use of single or multiple Ps does not guarantee diagnosis. Predictive performance indicated that poikilothermia, pallor, and paralysis are not significantly informative. Conclusion: The presence of specific patterns of clinical signs/symptoms associated with ACS seems to influence a surgeon's decision to perform fasciotomy. These data question the gold standard of clinical signs for diagnosis of ACS. The reliance on the Ps classically taught in medical school does not seem to be sufficient for accurate diagnosis. Objective measures such as continuous pressure or a physiologic marker of ischemia may be better indications for compartment syndrome. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 April 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (2)
Open AccessRethinking the Paradigm of Using Ps for Diagnosing Compartment Syndrome
Background: To evaluate the predictive power of 7 clinical signs and symptoms associated with acute compartment syndrome (ACS) of the leg, namely pain, paresthesia, paralysis, pallor, poikilothermia, pulselessness, and pressure on palpation (7P's). Methods: Retrospective data of 357 patients were obtained from the databases of 5-level one trauma centers in Canada, the United States, and France. Inclusion criteria were patients with tibia injuries that received fasciotomies in adults with documented serial clinical assessments. All possible combinations of signs/symptoms used were generated. The combinations were tested for predictive power using 2 machine learning algorithms. Results: Pressure on palpation was the strongest clinical predictor of ACS while pain was the weakest. Using any single P to assess for ACS yields a poor prediction. Increasing the number of Ps improves the performance up to 4Ps, regardless of the composition of the combination. None of the combinations had a perfect predictive power which means that the use of single or multiple Ps does not guarantee diagnosis. Predictive performance indicated that poikilothermia, pallor, and paralysis are not significantly informative. Conclusion: The presence of specific patterns of clinical signs/symptoms associated with ACS seems to influence a surgeon's decision to perform fasciotomy. These data question the gold standard of clinical signs for diagnosis of ACS. The reliance on the Ps classically taught in medical school does not seem to be sufficient for accurate diagnosis. Objective measures such as continuous pressure or a physiologic marker of ischemia may be better indications for compartment syndrome. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Supplemental tables, figures, and list of participants
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Supplemental tables, figures, and list of participants
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Data from Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Among 2,186 U.S. adults with invasive cancer and laboratory-confirmed SARS-CoV-2 infection, we examined the association of COVID-19 treatments with 30-day all-cause mortality and factors associated with treatment. Logistic regression with multiple adjustments (e.g., comorbidities, cancer status, baseline COVID-19 severity) was performed. Hydroxychloroquine with any other drug was associated with increased mortality versus treatment with any COVID-19 treatment other than hydroxychloroquine or untreated controls; this association was not present with hydroxychloroquine alone. Remdesivir had numerically reduced mortality versus untreated controls that did not reach statistical significance. Baseline COVID-19 severity was strongly associated with receipt of any treatment. Black patients were approximately half as likely to receive remdesivir as white patients. Although observational studies can be limited by potential unmeasured confounding, our findings add to the emerging understanding of patterns of care for patients with cancer and COVID-19 and support evaluation of emerging treatments through inclusive prospective controlled trials.Significance:Evaluating the potential role of COVID-19 treatments in patients with cancer in a large observational study, there was no statistically significant 30-day all-cause mortality benefit with hydroxychloroquine or high-dose corticosteroids alone or in combination; remdesivir showed potential benefit. Treatment receipt reflects clinical decision-making and suggests disparities in medication access.This article is highlighted in the In This Issue feature, p. 1426
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Among 2,186 U.S. adults with invasive cancer and laboratory-confirmed SARS-CoV-2 infection, we examined the association of COVID-19 treatments with 30-day all-cause mortality and factors associated with treatment. Logistic regression with multiple adjustments (e.g., comorbidities, cancer status, baseline COVID-19 severity) was performed. Hydroxychloroquine with any other drug was associated with increased mortality versus treatment with any COVID-19 treatment other than hydroxychloroquine or untreated controls; this association was not present with hydroxychloroquine alone. Remdesivir had numerically reduced mortality versus untreated controls that did not reach statistical significance. Baseline COVID-19 severity was strongly associated with receipt of any treatment. Black patients were approximately half as likely to receive remdesivir as white patients. Although observational studies can be limited by potential unmeasured confounding, our findings add to the emerging understanding of patterns of care for patients with cancer and COVID-19 and support evaluation of emerging treatments through inclusive prospective controlled trials.Significance:Evaluating the potential role of COVID-19 treatments in patients with cancer in a large observational study, there was no statistically significant 30-day all-cause mortality benefit with hydroxychloroquine or high-dose corticosteroids alone or in combination; remdesivir showed potential benefit. Treatment receipt reflects clinical decision-making and suggests disparities in medication access.This article is highlighted in the In This Issue feature, p. 1426
- 31 December 2021
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 30 (5) , 185-188
The Extremity War Injury Symposium: Emerging Combat and Readiness Research
- 31 December 2021
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 30 (5) , 185-188
The Extremity War Injury Symposium: Emerging Combat and Readiness Research
- 12 November 2020
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 29 (1) , e1-e4
AAOS Clinical Practice Guideline: Management of Acute Compartment Syndrome
- 12 November 2020
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 29 (1) , e1-e4
AAOS Clinical Practice Guideline: Management of Acute Compartment Syndrome
- 18 February 2020
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 34 (6) , 294-301
Open Reduction Is Associated With Greater Hazard of Early Reoperation After Internal Fixation of Displaced Femoral Neck Fractures in Adults 18–65 Years
Objectives: To determine (1) which factors are associated with the choice to perform an open reduction and (2) by adjusting for these factors, if the choice of reduction method is associated with reoperation. Design: Retrospective cohort study with radiograph and chart review. Setting: Twelve Level 1 North American trauma centers. Patients: Two hundred thirty-four adults 18–65 years of age with an isolated, displaced, OTA/AO type 31-B2 or type 31-B3 femoral neck fracture treated with internal fixation with minimum of 6-month follow-up or reoperation. Exclusion criteria were pathologic fractures, associated femoral head or shaft fractures, and primary arthroplasty. Intervention: Open or closed reduction technique during internal fixation. Main outcome: Cox proportional hazard of reoperation adjusting for propensity score for open reduction based on injury, demographic, and medical factors. Reduction quality was assessed by 3 senior orthopaedic traumatologists as “acceptable” or “unacceptable” on AP and lateral postoperative radiographs. Results: Median follow-up was 1.5 years. One hundred six (45%) patients underwent open reduction. Reduction quality was not significantly affected by open versus closed approach (71% vs. 69% acceptable, P = 0.378). The propensity to receive an open reduction was associated with study center; younger age; male sex; no history of injection drug use, osteoporosis, or cerebrovascular disease; transcervical fracture location; posterior fracture comminution; and surgery within 12 hours. A total of 35 (33%) versus 28 (22%) reoperations occurred after open versus closed reduction (P = 0.056). Open reduction was associated with a 2.4-fold greater propensity-adjusted hazard of reoperation (95% confidence interval 1.3–4.4, P = 0.004). A total of 35 (15%) patients underwent subsequent total hip arthroplasty or hemiarthroplasty. Conclusions: Open reduction of displaced femoral neck fractures in nonelderly adults is associated with a greater hazard of reoperation without significantly improving reduction. Prospective randomized trials are indicated to confirm a causative effect of open versus closed reduction on outcomes after femoral neck fracture. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 18 February 2020
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 34 (6) , 294-301
Open Reduction Is Associated With Greater Hazard of Early Reoperation After Internal Fixation of Displaced Femoral Neck Fractures in Adults 18–65 Years
Objectives: To determine (1) which factors are associated with the choice to perform an open reduction and (2) by adjusting for these factors, if the choice of reduction method is associated with reoperation. Design: Retrospective cohort study with radiograph and chart review. Setting: Twelve Level 1 North American trauma centers. Patients: Two hundred thirty-four adults 18–65 years of age with an isolated, displaced, OTA/AO type 31-B2 or type 31-B3 femoral neck fracture treated with internal fixation with minimum of 6-month follow-up or reoperation. Exclusion criteria were pathologic fractures, associated femoral head or shaft fractures, and primary arthroplasty. Intervention: Open or closed reduction technique during internal fixation. Main outcome: Cox proportional hazard of reoperation adjusting for propensity score for open reduction based on injury, demographic, and medical factors. Reduction quality was assessed by 3 senior orthopaedic traumatologists as “acceptable” or “unacceptable” on AP and lateral postoperative radiographs. Results: Median follow-up was 1.5 years. One hundred six (45%) patients underwent open reduction. Reduction quality was not significantly affected by open versus closed approach (71% vs. 69% acceptable, P = 0.378). The propensity to receive an open reduction was associated with study center; younger age; male sex; no history of injection drug use, osteoporosis, or cerebrovascular disease; transcervical fracture location; posterior fracture comminution; and surgery within 12 hours. A total of 35 (33%) versus 28 (22%) reoperations occurred after open versus closed reduction (P = 0.056). Open reduction was associated with a 2.4-fold greater propensity-adjusted hazard of reoperation (95% confidence interval 1.3–4.4, P = 0.004). A total of 35 (15%) patients underwent subsequent total hip arthroplasty or hemiarthroplasty. Conclusions: Open reduction of displaced femoral neck fractures in nonelderly adults is associated with a greater hazard of reoperation without significantly improving reduction. Prospective randomized trials are indicated to confirm a causative effect of open versus closed reduction on outcomes after femoral neck fracture. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 3 December 2019
- Published by Springer Nature
- p. 1-3
Introduction and Scope of the Problem
- Open Access
- 3 September 2019
- Published by Springer Nature
- p. 169-176
Novel Modalities to Diagnose and Prevent Compartment Syndrome
- 3 September 2019
- Published by Springer Nature
- p. 169-176
Open AccessNovel Modalities to Diagnose and Prevent Compartment Syndrome
- 3 May 2019
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 32 (05) , 387
Periprosthetic Fractures
It is a privilege to serve as the guest editor of this “Special Focus Issue” of The Journal of Knee Surgery on the topic of periprosthetic fractures about the knee. I have selected three papers that I believe will be valuable to readers interested in this topic. First, Dr. Borade and colleagues contribute a thorough review article describing surgical techniques for minimally invasive plate osteosynthesis for peri- and interprosthetic fractures. This article also includes a review of the literature that provides the reader with up-to-date information to manage all types of periprosthetic fractures about the knee, including interprosthetic fractures, and both primary or revision components. A new technique that is attracting significant interest for problematic distal femoral fractures is that of combined nailing and plating. Because of this, Dr. Mirick was requested to provide a specific article detailing the use of this specific surgical approach to periprosthetic fractures of the distal femur. Readers of this article will find a nice summary of the indications, contraindications, and surgical technique. Finally, any series of articles on these injuries would not be completed without a discussion on distal femoral replacement (DFR). Dr. Khan provides a nice summary of the current belief regarding DFR as a treatment option for periprosthetic fractures of the knee, describing the technique, outcomes, and complications. I hope readers, after reviewing these three manuscripts, will have an updated understanding of the state-of-the-art related to treating periprosthetic knee fractures, for internal fixation as well as arthroplasty options, and the technical subtleties of these various techniques for surgical management of patients with periprosthetic fractures around total knee arthroplasty.
- 3 May 2019
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 32 (05) , 387
Periprosthetic Fractures
It is a privilege to serve as the guest editor of this “Special Focus Issue” of The Journal of Knee Surgery on the topic of periprosthetic fractures about the knee. I have selected three papers that I believe will be valuable to readers interested in this topic. First, Dr. Borade and colleagues contribute a thorough review article describing surgical techniques for minimally invasive plate osteosynthesis for peri- and interprosthetic fractures. This article also includes a review of the literature that provides the reader with up-to-date information to manage all types of periprosthetic fractures about the knee, including interprosthetic fractures, and both primary or revision components. A new technique that is attracting significant interest for problematic distal femoral fractures is that of combined nailing and plating. Because of this, Dr. Mirick was requested to provide a specific article detailing the use of this specific surgical approach to periprosthetic fractures of the distal femur. Readers of this article will find a nice summary of the indications, contraindications, and surgical technique. Finally, any series of articles on these injuries would not be completed without a discussion on distal femoral replacement (DFR). Dr. Khan provides a nice summary of the current belief regarding DFR as a treatment option for periprosthetic fractures of the knee, describing the technique, outcomes, and complications. I hope readers, after reviewing these three manuscripts, will have an updated understanding of the state-of-the-art related to treating periprosthetic knee fractures, for internal fixation as well as arthroplasty options, and the technical subtleties of these various techniques for surgical management of patients with periprosthetic fractures around total knee arthroplasty.